早发性卒中患者中孟德尔卒中基因突变的患病率
研究纳入全国性前瞻性多中心卒中登记中年龄≤55岁的卒中或短暂性脑缺血发作患者,用定制靶向二代测序面板检测15个孟德尔卒中基因的临床相关遗传变异(CRGV)。在1033例患者中131例(12.7%)携带28种CRGV,以RNF213最多见(59例),其次ABCC6(53例)和NOTCH3(15例);CRGV频率因缺血性卒中亚型及年龄组而异,且多数携带者缺乏相应单基因病的典型神经影像特征。
要点
- 1033例≤55岁卒中或短暂性脑缺血发作患者中,131例(12.7%)检出28种孟德尔卒中基因的临床相关遗传变异。
- CRGV最常见于RNF213(59例),其次ABCC6(53例)和NOTCH3(15例)。
- RNF213和NOTCH3变异携带者中仅27.1%和26.7%具有相应疾病的典型神经影像特征。
核心结论
- 15个孟德尔卒中基因的临床相关遗传变异在年轻卒中人群中可能并不少见。
- 大多数携带临床相关遗传变异的患者不具有相应单基因病的典型特征。
- 携带临床相关遗传变异或意义不明变异者的临床意义有待探索。
研究设计与样本
- 研究纳入来自前瞻性、全国性、多中心卒中登记的年龄≤55岁卒中或短暂性脑缺血发作患者。
- 采用定制靶向二代测序面板检测15个孟德尔卒中基因(GLA、NOTCH3、HTRA1、RNF213、ACVRL1、ENG、CBS、TREX1、ABCC6、COL4A1、FBN1、NF1、COL3A1、MT-TL1和APP)的临床相关遗传变异。
- 共纳入1033例患者。
主要发现
- 1033例患者中131例(12.7%)携带28种临床相关遗传变异,最常见于RNF213(59例),其次ABCC6(53例)和NOTCH3(15例)。
- 临床相关遗传变异频率因缺血性卒中亚型而异(p < 0.01):其他明确病因型最高(20.1%),其次大动脉粥样硬化型(13.6%)。
- 年龄≤35岁患者与51至55岁患者的临床相关遗传变异频率分别为17.1%与9.3%(p = 0.02)。
- RNF213和NOTCH3变异携带者中仅27.1%和26.7%分别具有相应疾病的典型神经影像特征。
- 15.4%的患者发现意义不明变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Heritability of stroke is assumed not to be low, especially in the young stroke population. However, most genetic studies have been performed in highly selected patients with typical clinical or neuroimaging characteristics. We investigated the prevalence of 15 Mendelian stroke genes and explored the relationships between variants and the clinical and neuroimaging characteristics in a large, unselected, young stroke population. METHODS: We enrolled patients aged ≤55 years with stroke or transient ischemic attack from a prospective, nationwide, multicenter stroke registry. We identified clinically relevant genetic variants (CRGVs) in 15 Mendelian stroke genes (GLA, NOTCH3, HTRA1, RNF213, ACVRL1, ENG, CBS, TREX1, ABCC6, COL4A1, FBN1, NF1, COL3A1, MT-TL1, and APP) using a customized, targeted next generation sequencing panel. RESULTS: Among 1,033 patients, 131 (12.7%) had 28 CRGVs, most frequently in RNF213 (n = 59), followed by ABCC6 (n = 53) and NOTCH3 (n = 15). The frequency of CRGVs differed by ischemic stroke subtypes (p < 0.01): the highest in other determined etiology (20.1%), followed by large artery atherosclerosis (13.6%). It also differed between patients aged ≤35 years and those aged 51 to 55 years (17.1% vs 9.3%, p = 0.02). Only 27.1% and 26.7% of patients with RNF213 and NOTCH3 variants had typical neuroimaging features of the corresponding disorders, respectively. Variants of uncertain significance (VUSs) were found in 15.4% patients. INTERPRETATION: CRGVs in 15 Mendelian stroke genes may not be uncommon in the young stroke population. The majority of patients with CRGVs did not have typical features of the corresponding monogenic disorders. Clinical implications of having CRGVs or VUSs should be explored. ANN NEUROL 2023;93:768-782.
引用
- Park HK, Lee KJ, Park JM, et al. Prevalence of Mutations in Mendelian Stroke Genes in Early Onset Stroke Patients. Ann Neurol. 2023. PMID: 36541592. doi:10.1002/ana.26575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。